II
JAZZ icon

Inspire Investing’s Jazz Pharmaceuticals JAZZ Stock Holding History

Inspire Investing’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Sell
5,498
-2,152
-28% -$376K 0.06% 325
2025
Q4 		$1.3M Buy
+7,650
New +$1.17M 0.12% 187
2025
Q2 		– Sell
-5,547
Closed -$689K – 847
2025
Q1 		$689K Buy
+5,547
New +$724K 0.08% 245
2024
Q4 		– Sell
-2,798
Closed -$312K – 839
2024
Q3 		$312K Buy
+2,798
New +$307K 0.03% 758

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Inspire Investing's JAZZ Position: Q1 2026 in Review

Inspire Investing reduced its Jazz Pharmaceuticals (JAZZ) stake by 28% in Q1 2026, selling an estimated $376K and leaving 5,498 shares worth $1.04M. The position accounts for 0.06% of the portfolio, ranked #325.

Inspire Investing first reported a position in JAZZ in Q3 2024 and has held it in 4 quarters since. The position peaked at $1.3M in Q4 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Inspire Investing held 5,498 shares of Jazz Pharmaceuticals worth $1.04M as of Q1 2026.
  • Inspire Investing sold 2,152 Jazz Pharmaceuticals shares in Q1 2026, an estimated $376K.
  • Jazz Pharmaceuticals made up 0.06% of Inspire Investing's portfolio in Q1 2026, its #325 holding.
  • Inspire Investing first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • Inspire Investing's Jazz Pharmaceuticals position peaked at $1.3M in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.